Edition:
United States

Proteostasis Therapeutics Inc (PTI.OQ)

PTI.OQ on NASDAQ Stock Exchange Global Market

2.53USD
25 Sep 2018
Change (% chg)

$0.02 (+0.80%)
Prev Close
$2.51
Open
$2.53
Day's High
$2.53
Day's Low
$2.53
Volume
643
Avg. Vol
92,770
52-wk High
$8.61
52-wk Low
$1.41

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Jun '18 0.84 -0.430
Mar '18 0.94 -0.320
FY 2017 Dec '17 1.62 -0.507
Sep '17 1.55 -0.556
Jun '17 1.15 -0.677
Mar '17 1.02 -0.603
FY 2016 Dec '16 4.06 -0.376
Sep '16 1.72 -0.537
Jun '16 1.45 -0.473
Mar '16 1.16 -0.870
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 2 1.13 1.40 0.85 --
Quarter Ending Dec-18 2 1.13 1.40 0.86 --
Year Ending Dec-18 2 4.04 4.59 3.50 1.00
Year Ending Dec-19 2 4.17 4.81 3.53 0.50
Earnings (per share)
Quarter Ending Sep-18 2 -0.43 -0.40 -0.45 --
Quarter Ending Dec-18 2 -0.38 -0.29 -0.47 --
Year Ending Dec-18 2 -1.56 -1.44 -1.68 -2.62
Year Ending Dec-19 2 -1.47 -1.13 -1.81 -2.81
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 109.17 32.55
P/E High - Last 5 Yrs. -- 280.12 47.13
P/E Low - Last 5 Yrs. -- 98.84 24.86
Beta -- 0.61 0.87
Price to Sales (TTM) 18.58 110.45 6.32
Price to Book (MRQ) 1.63 12.64 3.96
Price to Tangible Book (MRQ) 1.64 19.10 6.00
Price to Cash Flow (TTM) -- 63.46 22.84
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.35 1.68
Dividend Yield - 5 Year Avg -- 0.21 1.45
Dividend 5 Year Growth Rate -- 2.60 -5.90
Payout Ratio(TTM) -- 5.94 46.65

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -26.50 175.06 8.33
Sales (TTM) vs TTM 1 Yr. Ago -37.58 95.32 6.69
Sales - 5 Yr. Growth Rate -- 24.62 7.54
EPS (MRQ) vs Qtr. 1 Yr. Ago 36.53 282.02 25.23
EPS (TTM) vs TTM 1 Yr. Ago 17.36 -- --
EPS - 5 Yr. Growth Rate -- 23.81 7.60
Capital Spending - 5 Yr. Growth Rate -- 38.47 8.36

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.21
Current Ratio (MRQ) 6.70 5.52 2.98
LT Debt to Equity (MRQ) 0.00 15.14 11.20
Total Debt to Equity (MRQ) 0.00 18.66 14.01
Interest Coverage (TTM) -- -209.98 34.72

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.96 54.70
Gross Margin - 5 Yr. Avg. -- 52.62 53.20
EBITD Margin (TTM) -1,076.99 -- --
EBITD - 5 Yr. Avg -- -178.18 15.84
Operating Margin (TTM) -1,101.05 -606.83 3.87
Operating Margin - 5 Yr. Avg. -- -191.65 10.99
Pre-Tax Margin (TTM) -1,086.77 -603.48 4.20
Pre-Tax Margin - 5 Yr. Avg. -- -194.31 11.19
Net Profit Margin (TTM) -1,086.77 -598.39 0.91
Net Profit Margin - 5 Yr. Avg. -- -191.85 7.51
Effective Tax Rate (TTM) -- 11.63 20.56
Effective Tax Rate - 5 Yr. Avg. -- 19.21 24.33

Efficiency

  Company industry sector
Revenue/Employee (TTM) 99,160 5,345,588 725,212,627
Net Income/Employee (TTM) -1,077,640 -5,897,254 83,818,761
Receivable Turnover (TTM) -- 4.23 5.04
Inventory Turnover (TTM) -- 2.07 3.63
Asset Turnover (TTM) 0.07 0.38 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -76.14 0.80 9.83
Return on Assets - 5 Yr. Avg. -- 2.68 10.96
Return on Investment (TTM) -88.88 1.47 12.80
Return on Investment - 5 Yr. Avg. -- 2.23 14.08
Return on Equity (TTM) -100.26 0.22 14.92
Return on Equity - 5 Yr. Avg. -- -2.55 15.41
  1 Year 3 Year 5 Year
Sales % -36.30 1.22 --
EPS (TTM) % -13.65 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Proteostasis Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 65.14%
# of Holders: 83
Total Shares Held: 23,904,081
3 Mo. Net Change: -575,988
# New Positions: 31
# Closed Positions: 15
# Increased Positions: 60
# Reduced Positions: 25
# Net Buyers: 35
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.